Martin Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.15M Sell
14,252
-334
-2% -$160K 2.39% 17
2026
Q1
$7.17M Buy
14,586
+7
+0% +$3.8K 2.15% 19
2025
Q4
$8.45M Sell
14,579
-721
-5% -$408K 2.36% 15
2025
Q3
$7.42M Sell
15,300
-358
-2% -$167K 1.89% 19
2025
Q2
$6.35M Sell
15,658
-109
-0.7% -$45.6K 1.63% 26
2025
Q1
$7.85M Buy
15,767
+851
+6% +$461K 1.98% 17
2024
Q4
$7.76M Sell
14,916
-2,122
-12% -$1.17M 2.13% 15
2024
Q3
$10.5M Buy
17,038
+190
+1% +$112K 2.58% 14
2024
Q2
$9.32M Sell
16,848
-627
-4% -$359K 2.39% 14
2024
Q1
$10.2M Sell
17,475
-97
-0.6% -$54.4K 2.5% 14
2023
Q4
$9.33M Sell
17,572
-1,658
-9% -$803K 2.78% 12
2023
Q3
$9.73M Sell
19,230
-857
-4% -$457K 2.92% 12
2023
Q2
$10.5M Sell
20,087
-658
-3% -$355K 2.96% 11
2023
Q1
$12M Sell
20,745
-1,190
-5% -$671K 3.44% 8
2022
Q4
$12.1M Buy
21,935
+321
+1% +$170K 3.79% 8
2022
Q3
$11M Sell
21,614
-46
-0.2% -$25.7K 3.84% 8
2022
Q2
$11.8M Sell
21,660
-368
-2% -$203K 3.33% 9
2022
Q1
$13M Buy
22,028
+1,842
+9% +$1.06M 3.3% 9
2021
Q4
$13.5M Sell
20,186
-385
-2% -$240K 3.34% 9
2021
Q3
$11.8M Sell
20,571
-7
-0% -$3.84K 2.96% 12
2021
Q2
$10.4M Buy
20,578
+193
+0.9% +$91.1K 2.67% 13
2021
Q1
$9.3M Sell
20,385
-80
-0.4% -$38.2K 2.63% 15
2020
Q4
$9.53M Sell
20,465
-372
-2% -$174K 3.05% 11
2020
Q3
$9.2M Buy
20,837
+553
+3% +$228K 3.32% 11
2020
Q2
$7.35M Buy
20,284
+212
+1% +$71.1K 3.06% 10
2020
Q1
$5.69M Sell
20,072
-4,968
-20% -$1.57M 2.88% 10
2019
Q4
$8.13M Sell
25,040
-22,346
-47% -$6.78M 2.82% 13
2019
Q3
$13.8M Sell
47,386
-2,365
-5% -$677K 3.38% 8
2019
Q2
$14.6M Sell
49,751
-8,301
-14% -$2.29M 3.67% 4
2019
Q1
$15.9M Sell
58,052
-257
-0.4% -$64K 4.14% 5
2018
Q4
$13M Sell
58,309
-1,359
-2% -$319K 4.2% 4
2018
Q3
$14.6M Sell
59,668
-12,644
-17% -$2.91M 3.91% 5
2018
Q2
$15M Sell
72,312
-141
-0.2% -$29.9K 3.77% 7
2018
Q1
$15M Buy
72,453
+1,598
+2% +$335K 3.79% 6
2017
Q4
$13.4M Hold
70,855
3.74% 7
2017
Q3
$13.4M Sell
70,855
-2,096
-3% -$380K 3.74% 7
2017
Q2
$12.7M Sell
72,951
-1,486
-2% -$250K 3.59% 10
2017
Q1
$11.4M Sell
74,437
-29,156
-28% -$4.46M 3.23% 11
2016
Q4
$14.6M Sell
103,593
-35,952
-26% -$5.3M 2.77% 14
2016
Q3
$22.2M Sell
139,545
-1,495
-1% -$230K 3.66% 7
2016
Q2
$20.8M Sell
141,040
-25,667
-15% -$3.79M 3.48% 10
2016
Q1
$23.6M Sell
166,707
-3,856
-2% -$517K 3.68% 8
2015
Q4
$24.2M Sell
170,563
-12,357
-7% -$1.65M 3.84% 8
2015
Q3
$22.4M Sell
182,920
-10,163
-5% -$1.32M 3.61% 10
2015
Q2
$25.1M Sell
193,083
-3,242
-2% -$423K 3.59% 7
2015
Q1
$26.4M Buy
196,325
+23,359
+14% +$3.01M 3.68% 6
2014
Q4
$21.7M Sell
172,966
-6,983
-4% -$849K 3.57% 6
2014
Q3
$21.9M Sell
179,949
-9,949
-5% -$1.21M 3.87% 6
2014
Q2
$22.4M Sell
189,898
-255
-0.1% -$30K 4.02% 6
2014
Q1
$22.9M Sell
190,153
-9,969
-5% -$1.19M 4.35% 4
2013
Q4
$22.3M Buy
200,122
+3,590
+2% +$357K 4.11% 5
2013
Q3
$18.1M Sell
196,532
-6,132
-3% -$555K 3.93% 5
2013
Q2
$17.2M Buy
+202,664
New +$16.9M 4.06% 5

Other funds holding TMO

Martin Investment Management's TMO Position: Q2 2026 in Review

Martin Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 2.3% in Q2 2026, selling an estimated $160K and leaving 14,252 shares worth $7.15M. The position accounts for 2.39% of the portfolio, ranked #17.

Martin Investment Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $26.4M in Q1 2015. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Martin Investment Management held 14,252 shares of Thermo Fisher Scientific worth $7.15M as of Q2 2026.
  • Martin Investment Management sold 334 Thermo Fisher Scientific shares in Q2 2026, an estimated $160K.
  • Thermo Fisher Scientific made up 2.39% of Martin Investment Management's portfolio in Q2 2026, its #17 holding.
  • Martin Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Martin Investment Management's Thermo Fisher Scientific position peaked at $26.4M in Q1 2015.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Martin Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.